[1]
T. Sacha, J. Góra-Tybor, and S. Szmit, “The effect of tyrosine kinase inhibitors used in the treatment of chronic myeloid leukemia on the cardiovascular system”, OncoReview, vol. 9, no. 1(33), pp. 3-21, Mar. 2019.